OptimizeRx names new CFO and CAO, effective January 2027
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
August 12, 2026 4:05 PM EDTThe Company Names Andy DSilva as the next Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027
Planned Transition Reflects Strong Succession Planning and Deep Leadership Bench
WALTHAM, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the Company) (Nasdaq: OPRX), a leading healthcare technology company enabling life sciences organizations to deliver smarter, more personalized engagement across the healthcare ecosystem, today announced a finance leadership transition that reflects the Companys disciplined succession planning, deep leadership bench, and confidence in its... More
